Abstract
With recent technical development, new imaging methods are rapidly introduced and creative use of them improves drug development and clinical application. But small numbers of them are integrated in the clinical use. For this reason, understanding the meaning of biomarker and the methodological strategy for validation are important. The purpose of this comment is to explore the basis for the use of imaging biomarker in clinical setting.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Lee, J.W., Devanarayan, V., Barrett, Y.C., et al.: Fit-for-purpose method development and validation for successful biomarker measurement. Pharm. Res. 23, 312–328 (2006)
Frank, R., Hargreaves, R.: Clinical biomarkers in drug discovery and development. Nat. Rev. Drug Discov. 2, 566–580 (2003)
Smith, J.J., Sorensen, A.G., Thrall, J.H.: Biomarkers in imaging: realizing radiology’s future. Radiology 227, 633–638 (2003)
Annas, G.J.: Faith (healing), hope and charity at the FDA: the politics of AIDS drug trials. Villanova Law Rev. 34, 771–797 (1989)
Schuster, D.P.: The opportunities and challenges of developing imaging biomarkers to study lung function and disease. Am. J. Respir. Crit. Care Med. 176, 224–230 (2007)
Kelloff, G.J., Hoffman, J.M., Johnson, B., et al.: Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin. Cancer Res. 11, 2785–2808 (2005)
Choi, H.J., Kim, S.H., Seo, S.S., et al.: MRI for pretreatment lymph node staging in uterine cervical cancer. AJR Am. J. Roentgenol. 187, W538–W543 (2006)
Oh, J., Henry, R.G., Pirzkall, A., et al.: Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume. J. Magn. Reson. Imaging 19, 546–554 (2004)
Katz-Brull, R., Lavin, P.T., Lenkinski, R.E.: Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J. Natl. Cancer Inst. 94, 1197–1203 (2002)
Swindle, P., McCredie, S., Russell, P., et al.: Pathologic characterization of human prostate tissue with proton MR spectroscopy. Radiology 228, 144–151 (2003)
Bezabeh, T., Smith, I.C., Krupnik, E., et al.: Diagnostic potential for cancer via 1H magnetic resonance spectroscopy of colon tissue. Anticancer Res. 16, 1553–1558 (1996)
Mahon, M.M., Williams, A.D., Soutter, W.P., et al.: 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration. NMR Biomed. 17, 1–9 (2004)
Villringer, A., Rosen, B.R., Belliveau, J.W., et al.: Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn. Reson. Med. 6, 164–174 (1988)
Le Bihan, D.: Looking into the functional architecture of the brain with diffusion MRI. Nat. Rev. Neurosci. 4, 469–480 (2003)
Heugen, U., Schwaab, G., Bründermann, E., et al.: Solute-induced retardation of water dynamics probed directly by terahertz spectroscopy. Proc. Natl. Acad. Sci. 103, 12301–12306 (2006)
Vij, J.K., Simpson, D.R.J., Panarina, O.E.: Far infrared spectroscopy of water at different temperatures: GHz to THz dielectric spectroscopy of water. J. Mol. Liq. 112, 125–135 (2004)
Zhuang, W., Feng, Y., Prohofsky, E.W.: Self-consistent calculation of localized DNA vibrational properties at a double-helix-single-strand junction with anharmonic potential. Phys. Rev. A 41, 7033–7042 (1990)
Young, L., Prabhu, V.V., Prohofsky, E.W., Edwards, G.S.: Prediction of modes with dominant base roll and propeller twist in B-DNA poly(dA)-poly(dT). Phys. Rev. A 41, 7020–7023 (1990)
Fischer, B., Hoffmann, M., Helm, H., et al.: Terahertz time-domain spectroscopy and imaging of artificial RNA. Opt. Express 13, 5205–5215 (2005)
Markelz, A.G., Knab, J.R., Chen, J.Y., He, Y.: Protein dynamical transition in terahertz dielectric response. Chem. Phys. Lett. 442, 413–417 (2007)
Kutteruf, M.R., Brown, C.M., Iwaki, L.K., Campbell, M.B., Korter, T.M., Heilweil, E.J.: Terahertz spectroscopy of short-chain polypeptides. Chem. Phys. Lett. 375, 337–343 (2003)
Fitzgerald, A.J., Wallace, V.P., Jimenez-Linan, M., et al.: Terahertz Pulsed Imaging of Human Breast Tumors1. Radiology 239, 533–540 (2006)
Wallace, V.P., Fitzgerald, A.J., Shankar, S., et al.: Terahertz pulsed imaging of basal cell carcinoma ex vivo and in vivo. Br. J. Dermatol. 151, 424–432 (2004)
Woodward, R.M., Wallace, V.P., Pye, R.J., et al.: Terahertz pulse imaging of ex vivo basal cell carcinoma. J. Investig. Dermatol. 120, 72–78 (2003)
Park, JY., Choi, HJ., Cho, K-S., Kim, K-R., Son, J-H.: Terahertz spectroscopic imaging of a rabbit VX2 hepatoma model. J. Appl. Phy. 109:064704-064704-064704
Oh, S.J., Kang, J., Maeng, I., et al.: Nanoparticle-enabled terahertz imaging for cancer diagnosis. Opt. Express 17, 3469–3475 (2009)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Choi, H.J., Son, JH. (2012). Imaging Biomarker. In: Park, GS., et al. Convergence of Terahertz Sciences in Biomedical Systems. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-3965-9_20
Download citation
DOI: https://doi.org/10.1007/978-94-007-3965-9_20
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-3964-2
Online ISBN: 978-94-007-3965-9
eBook Packages: Physics and AstronomyPhysics and Astronomy (R0)